Dongfang Lue
PrivateLast Round
Private Equity
Dec 23, 2019
Est. Valuation
$185.9M
Total Funding Raised
$42.9M
Company Overview
Dongfang Lue is a biopharmaceutical company focused on the research and development of DNA-based vaccines and therapies, notably for HPV-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dongfang Lue Comparables
Compare Dongfang Lue with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ApolloBio Corp. | 94% | |
| Luye Pharma Group | 78% | |
| Genexine Inc | 76% | |
Dongfang Lue Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Dec 23, 2019 | ||||
| Private Placement | Jan 1, 2017 | ||||
| Private Placement | Jun 1, 2016 | ||||
| Private Placement | Feb 29, 2016 | ||||
| Angel | Jul 1, 2006 |
Dongfang Lue Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Beijing Dongfang Gaosheng Holding Co., Ltd. | Private Placement |
Dongfang Lue Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Dongfang Lue's valuation, stock price, and market status.